Natco Pharma
-
Natco Pharma to set up Indonesia subsidiary
The total investment is of $3 million Hyderabad-based Natco Pharma said its board of directors has approved the incorporation of…
Read More » -
Natco Pharma gets US FDA nod for generic cancer treatment drug
Natco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celgene…
Read More » -
Natco Pharma seeks CDSCO approval for Molnupiravir capsules
The drug can be used for the treatment of corona virus Natco Pharma said it applied to the Central Drugs…
Read More » -
Natco Pharma board okays acquiring 1 per cent in Canadian arm
The company, however, did not disclose the value of the deal Drug major Natco Pharma said its board has approved…
Read More » -
USFDA gives nod to Natco’s marketing partner for cancer drug
There are plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the drug within the next few…
Read More » -
Natco Pharma launches epilepsy drug in India
The company has launched Brivaracetam tablets under brand BRECITA Natco Pharma has launched the epilepsy treatment drug ‘Brivaracetam’ in the…
Read More » -
Natco Pharma receives registration approval for Chlorantraniliprole
NATCO would be the first indigenous manufacturer of this technical product Natco Pharma announced its registration approval given by Central…
Read More » -
Natco Pharma launches anti blood clot medication
The company has launched the Rivaroxaban molecule under the brand name RPIGAT Natco Pharma has launched an anticoagulant medication in…
Read More » -
Natco Pharma’s partner gets US FDA nod for cancer treatment drug
In addition, Natco and Breckenridge have settled the patent litigation with Celgene in the US district court Natco Pharma said…
Read More » -
Natco Pharma Q2 net profit up 73 per cent to Rs 204 cr
Consolidated total income of the company stood at Rs 827.9 crore Natco Pharma reported a 73.23 per cent increase in…
Read More »